[1]
|
Ma’ayeh, M. and Costantine, M.M. (2020) Prevention of Preeclampsia. Seminars in Fetal and Neonatal Medicine, 25, Article ID: 101123. https://doi.org/10.1016/j.siny.2020.101123
|
[2]
|
Poniedziałek-Czajkowska, E., Mierzyński, R., Dłuski, D. and Leszczyńska-Gorzelak, B. (2021) Prevention of Hypertensive Disorders of Pregnancy—Is There a Place for Metformin? Journal of Clinical Medicine, 10, Article 2805.
https://doi.org/10.3390/jcm10132805
|
[3]
|
Broughton, P.F. (2001) Risk Factors for Preeclampsia. The New Eng-land Journal of Medicine, 344, 925-926.
|
[4]
|
Villar, J. and Belizán, J.M. (2000) Same Nutrient, Different Hypotheses: Disparities in Trials of Calcium Supplementation during Pregnancy. The American Journal of Clinical Nutrition, 71, 1375S-1379S.
https://doi.org/10.1093/ajcn/71.5.1375s
|
[5]
|
Hofmeyr, G., Atallah, A. and Duley, L. 2002) Calcium Supplementa-tion during Pregnancy for Preventing Hypertensive Disorders and Related Problems. In: Cochrane Database of System-atic Reviews, No. 1, CD001059.
https://doi.org/10.1002/14651858.CD001059
|
[6]
|
Chen, Q., Stone, P.R., McCowan, L.M.E. and Chamley, L.W. (2006) Phagocytosis of Necrotic but Not Apoptotic Trophoblasts Induces Endothelial Cell Activation. Hypertension, 47, 116-121.
https://doi.org/10.1161/01.HYP.0000196731.56062.7c
|
[7]
|
Chen, Q., et al. (2013) Pre-Treatment with Calcium Prevents Endothelial Cell Activation Induced by Multiple Activators, Necrotic Trophoblastic Debris or IL-6 or Preeclamptic Sera: Possible Relevance to the Pathogenesis of Preeclampsia. Placenta, 34, 1196-1201. https://doi.org/10.1016/j.placenta.2013.09.014
|
[8]
|
Cotter, A.M., Molloy, A.M., Scott, J.M. and Daly, S.F. (2001) Elevated Plasma Homocysteine in Early Pregnancy: A Risk Factor for the Development of severe Preeclampsia. Ameri-can Journal of Obstetrics & Gynecology, 185, 781-785.
https://doi.org/10.1067/mob.2001.117304
|
[9]
|
Schini-Kerth, V.B. (2003) Homocysteine, a Proinflammatory and Proatherosclerotic Factor: Role of Intracellular Reactive Oxygen Species. Circulation Research, 93, 271-273. https://doi.org/10.1161/01.RES.0000089561.87997.CF
|
[10]
|
Williams, P.J., Bulmer, J.N., Innes, B.A. and Broughton, P.F. (2011) Possible Roles for Folic Acid in the Regulation of Trophoblast Invasion and Placental Develop-ment in Normal Early Human Pregnancy. Biology of Reproduction, 84, 1148-1153.
https://doi.org/10.1095/biolreprod.110.088351
|
[11]
|
Wang, Y., et al. (2014) The Globular Heads of the C1q Re-ceptor Regulate Apoptosis in Human Extravillous Cytotrophoblast-Derived Transformed Cells via a Mitochon-dria-Dependent pathway. American Journal of Reproductive Immunology, 71, 73-85. https://doi.org/10.1111/aji.12160
|
[12]
|
Wang, F., Cao, G., Yi, W., Li, L. and Cao, X. (2019) Effect of Metformin on a Preeclampsia-Like Mouse Model Induced by High-Fat Diet. BioMed Research International, 2019, Article ID: 6547019.
https://doi.org/10.1155/2019/6547019
|
[13]
|
Luo, F., et al. (2019) Metformin in Patients with and without Diabetes: A Paradigm Shift in Cardiovascular Disease Management. Cardiovascular Diabetology, 18, Article No. 54. https://doi.org/10.1186/s12933-019-0860-y
|
[14]
|
Bakhashab, S., et al. (2016) Metformin Improves the Angiogenic Potential of Human CD34+ Cells Co-Incident with Downregulating CXCL10 and TIMP1 Gene Expression and Increas-ing VEGFA under Hyperglycemia and Hypoxia within a Therapeutic Window for Myocardial Infarction. Cardiovascular Diabetology, 15, Article No. 27.
https://doi.org/10.1186/s12933-016-0344-2
|
[15]
|
Brownfoot, F.C., et al. (2016) Metformin as a Prevention and Treatment for Preeclampsia: Effects on Soluble Fms-LIKE Tyrosine Kinase 1 and Soluble Endoglin Secretion and Endo-thelial Dysfunction. American Journal of Obstetrics & Gynecologyl, 214, e1-e356. https://doi.org/10.1016/j.ajog.2015.12.019
|
[16]
|
Cotechini, T. and Graham, C.H. (2015) Aberrant Maternal Inflam-mation as a Cause of Pregnancy Complications: A Potential Therapeutic Target? Placenta, 36, 960-966. https://doi.org/10.1016/j.placenta.2015.05.016
|
[17]
|
Li, S.-N., et al. (2009) Metformin Inhibits Nuclear Factor κB Activation and Decreases Serum High-Sensitivity C-Reactive Protein Level in Experimental Atherogenesis of Rabbits. Heart & Vessels, 24, 446-453.
https://doi.org/10.1007/s00380-008-1137-7
|
[18]
|
Kim, J., et al. (2014) Metformin Suppresses Lipopolysaccharide (LPS)-Induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) Induction. Journal of Biological Chemistry, 289, 23246-23255.
https://doi.org/10.1074/jbc.M114.577908
|
[19]
|
Hattori, Y., Suzuki, K., Hattori, S. and Kasai, K. (2006) Metformin Inhibits Cytokine-Induced Nuclear Factor κB Activation Via AMP-Activated Protein Kinase Activation in Vascular En-dothelial Cells. Hypertension, 47, 1183-1188.
https://doi.org/10.1161/01.HYP.0000221429.94591.72
|
[20]
|
Hu, J., Zhang, J. and Zhu, B. (2019) Protective Effect of Metformin on a Rat Model of Lipopolysaccharide-Induced Preeclampsia. Fundamental & Clinical Pharmacology, 33, 649-658. https://doi.org/10.1111/fcp.12501
|
[21]
|
Alqudah, A., et al. (2018) Risk of Pre-Eclampsia in Women Tak-ing Metformin: A Systematic Review and Meta-Analysis. Diabetic Medicine, 35, 160-172. https://doi.org/10.1111/dme.13523
|
[22]
|
Syngelaki, A., et al. (2016) Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. The New England Journal of Medicine, 374, 434-443. https://doi.org/10.1056/NEJMoa1509819
|
[23]
|
Costantine, M.M., et al. (2010) Using Pravastatin to Improve the Vascular Reactivity in a Mouse Model of Soluble Fms-Like Tyrosine Kinase-1-Induced Preeclampsia. Obstetrics & Gy-necology, 116, 114-120.
https://doi.org/10.1097/AOG.0b013e3181e10ebd
|
[24]
|
Esteve-Valverde, E., et al. (2018) Pravastatin for Preventing and Treating Preeclampsia: A Systematic Review. Obstetrics & Gynecology Survy, 73, 40-55. https://doi.org/10.1097/OGX.0000000000000522
|
[25]
|
Kumasawa, K., et al. (2011) Pravastatin Induces Placental Growth Factor (PGF) and Ameliorates Preeclampsia in a Mouse Model. PNAS, 108, 1451-1455. https://doi.org/10.1073/pnas.1011293108
|
[26]
|
Bauer, A.J. et al. (2013) Pravastatin Attenuates Hypertension, Oxi-dative Stress and Angiogenic Imbalance in Rat Model of Placental Ischemia-Induced Hypertension. Hypertension, 61, 1103-1110.
https://doi.org/10.1161/HYPERTENSIONAHA.111.00226
|
[27]
|
Ma’Ayeh, M., Rood, K.M., Kniss, D. and Cos-tantine, M.M. (2020) Novel Interventions for the Prevention of preeclampsia. Current Hypertension Reports, 22, Article No. 17. https://doi.org/10.1007/s11906-020-1026-8
|
[28]
|
Ahmed, A., et al. (2020) Pravastatin for Early-Onset Pre-Eclampsia: A Randomised, Blinded, Placebo-Controlled Trial. BJOG, 127, 478-488. https://doi.org/10.1111/1471-0528.16013
|
[29]
|
Costantine, M.M., et al. (2016) Safety and Pharmacokinetics of Pravastatin Used for the Prevention of Preeclampsia in High-Risk Pregnant Women: A Pilot Randomized Controlled Tri-al. American Journal of Obstetrics & Gynecology, 214, e1-e720. https://doi.org/10.1016/j.ajog.2015.12.038
|